Gaba International AG   Report issue

For profit Phase 4
Founded: Therwil Switzerland (1979)
Status: No NME R&D (1979)

Organization Overview

First Clinical Trial
2006
NCT00268138
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Alternative names

Gaba International AG | PD Dr. Christian Heumann

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dental Caries (Phase 4)

Gingivitis (Phase 4)

Inflammation (Phase 4)

Periodontitis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 7